Crystal structure of human CDK4 in complex with a D-type cyclin

The cyclin D1–cyclin-dependent kinase 4 (CDK4) complex is a key regulator of the transition through the G1 phase of the cell cycle. Among the cyclin/CDKs, CDK4 and cyclin D1 are the most frequently activated by somatic genetic alterations in multiple tumor types. Thus, aberrant regulation of the CDK4/cyclin D1 pathway plays an essential role in oncogenesis; hence, CDK4 is a genetically validated therapeutic target. Although X-ray crystallographic structures have been determined for various CDK/cyclin complexes, CDK4/cyclin D1 has remained highly refractory to structure determination. Here, we report the crystal structure of CDK4 in complex with cyclin D1 at a resolution of 2.3 Å. Although CDK4 is bound to cyclin D1 and has a phosphorylated T-loop, CDK4 is in an inactive conformation and the conformation of the heterodimer diverges from the previously known CDK/cyclin binary complexes, which suggests a unique mechanism for the process of CDK4 regulation and activation.

[1]  J. McCubrey,et al.  P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells , 2001, Oncogene.

[2]  M. Serrano,et al.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.

[3]  Louis Guillou,et al.  MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes: A Comparative Analysis of 559 Soft Tissue Neoplasms With Genetic Data , 2005, The American journal of surgical pathology.

[4]  L. Johnson,et al.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.

[5]  C. Sherr,et al.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase , 1994, Molecular and cellular biology.

[6]  K D Watenpaugh,et al.  The Cyclin-dependent Kinases cdk2 and cdk5 Act by a Random, Anticooperative Kinetic Mechanism* , 2001, The Journal of Biological Chemistry.

[7]  M. Noble,et al.  Reversal of Growth Suppression by p107 via Direct Phosphorylation by Cyclin D1/Cyclin-Dependent Kinase 4 , 2002, Molecular and Cellular Biology.

[8]  M. E. M. Noble,et al.  The structure of CDK4/cyclin D3 has implications for models of CDK activation , 2009, Proceedings of the National Academy of Sciences.

[9]  Manuel Serrano,et al.  Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d , 1998, Nature.

[10]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[11]  S. Cox,et al.  A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. , 2001, Cancer research.

[12]  N. Pavletich,et al.  Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. , 2000, Genes & development.

[13]  John A. Tainer,et al.  Kinetic Mechanism of Activation of the Cdk2/Cyclin A Complex , 2002, The Journal of Biological Chemistry.

[14]  T. McDonnell,et al.  Characterization of 4 mantle cell lymphoma cell lines. , 2003, Archives of pathology & laboratory medicine.

[15]  G J Kleywegt,et al.  Template convolution to enhance or detect structural features in macromolecular electron-density maps. , 1997, Acta crystallographica. Section D, Biological crystallography.

[16]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions , 2022 .

[17]  R. Hoess,et al.  Defining the substrate specificity of cdk4 kinase-cyclin D1 complex. , 1999, Carcinogenesis.

[18]  Tiansen Li,et al.  Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. , 2006, Cancer cell.

[19]  Y. De Launoit,et al.  Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK “Inhibitors” , 2006, Molecular and Cellular Biology.

[20]  Raju Tomer,et al.  Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. , 2004, Blood.

[21]  L. Johnson,et al.  The crystal structure of human CDK7 and its protein recognition properties. , 2004, Structure.

[22]  M. Barbacid,et al.  Cyclin D-dependent kinases, INK4 inhibitors and cancer. , 2002, Biochimica et biophysica acta.

[23]  L. Johnson,et al.  The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2‐independent roles , 2005, The EMBO journal.

[24]  A. Papanikolaou,et al.  Cyclin D1 in breast cancer pathogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[26]  M. Barbacid,et al.  To cycle or not to cycle: a critical decision in cancer , 2001, Nature reviews. Cancer.

[27]  Kornelia Polyak,et al.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex , 1995, Nature.

[28]  Rajesh P. N. Rao,et al.  Purification, Characterization, and Kinetic Mechanism of Cyclin D1·CDK4, a Major Target for Cell Cycle Regulation* , 1998, The Journal of Biological Chemistry.

[29]  L. Johnson,et al.  The structure of P‐TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation , 2008, The EMBO journal.

[30]  C. Auffray,et al.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.

[31]  K. Coulonval,et al.  Regulation of CDK4 , 2006, Cell Division.

[32]  R. Hoess,et al.  Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex. , 1998, Carcinogenesis.

[33]  E. Lees,et al.  Cyclin D-CDK Subunit Arrangement Is Dependent on the Availability of Competing INK4 and p21 Class Inhibitors , 1999, Molecular and Cellular Biology.

[34]  J. Massagué,et al.  Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4* , 1997, The Journal of Biological Chemistry.

[35]  K. G. Coleman,et al.  Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding* , 1997, The Journal of Biological Chemistry.

[36]  G. Bricogne,et al.  Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. , 2004, Acta crystallographica. Section D, Biological crystallography.

[37]  F. McCormick,et al.  The RB and p53 pathways in cancer. , 2002, Cancer cell.

[38]  N. Pattabiraman,et al.  Selectivity and potency of cyclin-dependent kinase inhibitors , 2006, The AAPS Journal.

[39]  Sung-Hou Kim,et al.  Structural basis for CDK6 activation by a virus-encoded cyclin , 2002, Nature Structural Biology.

[40]  Sung-Hou Kim,et al.  Crystal structure of cyclin-dependent kinase 2 , 1993, Nature.

[41]  M. Serrano,et al.  Activation of cyclin D1-kinase in murine fibroblasts lacking both p21Cip1 and p27Kip1 , 2002, Oncogene.

[42]  J. Herman,et al.  Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 , 2006, Oncogene.

[43]  R. Weinberg,et al.  Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Jeffrey,et al.  Structural basis of cyclin-dependent kinase activation by phosphorylation , 1996, Nature Structural Biology.

[45]  James M. Roberts,et al.  The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts , 1999, The EMBO journal.

[46]  P. Kaldis.  The N-terminal Peptide of the Kaposi's Sarcoma-associated Herpesvirus (KSHV)-cyclin Determines Substrate Specificity* , 2005, Journal of Biological Chemistry.

[47]  K. Ball,et al.  Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4 , 2004, Molecular and Cellular Biology.

[48]  F. Neipel,et al.  Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin , 1997, Journal of virology.

[49]  K. Arndt,et al.  Identification of a Conserved Sequence Motif That Promotes Cdc37 and Cyclin D1 Binding to Cdk4* , 2004, Journal of Biological Chemistry.

[50]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.